ShiraTronics的可植入装置每月将偏头痛减少9.6天,没有严重的副作用。 ShiraTronics' implantable device reduced migraines by 9.6 days monthly with no serious side effects.

ShiraTronics报告说,其RELIEV-CM试点研究12个月的结果是积极的,表明其调查性可移植神经调制疗法平均每月将头痛日减少9.6天,偏头痛日减少9.6天,平均减少9.6天,生活质量持续改善,救援用药减少,没有意外副作用。 ShiraTronics reported positive 12-month results from its RELIEV-CM Pilot Study, showing its investigational implantable neuromodulation therapy reduced monthly headache days by 9.6 and migraine days by 9.6 on average, with sustained improvements in quality of life, reduced rescue medication use, and no unexpected side effects. " ShiraTronics Migraine治疗系统 " 是一种首创、完全可植入的装置,它以偏头痛的关键路径为目标,向食道和超轨道神经提供受病人控制的电刺激。 The ShiraTronics Migraine Therapy System is a first-of-its-kind, fully implantable device that delivers patient-controlled electrical stimulation to the occipital and supraorbital nerves, targeting key pathways in migraine. 它旨在调节三重宫颈癌综合体的疼痛信号,为慢性偏头痛病人提供一种无药、持续的治疗选择,有可能解决目前疗法的局限性。 Designed to modulate pain signals in the trigeminocervical complex, it offers a drug-free, continuous treatment option for chronic migraine patients, potentially addressing limitations of current therapies.